• About
  • Submit Article/PR
  • Contact
Sunday, May 18, 2025
No Result
View All Result
  • Login
The Healthcare Daily
WHO COVID DASHBOARD
  • Home
  • News
    • All
    • Biotech
    • By Speciality
    • Generic Drugs
    • Insurance
    • Investment
    • Medical Tourism
    • Pharma
    Ixchiq-the-Chikungunya-Vaccine-Receives-FDA-Approval-thehealthcaredaily

    Ixchiq, the Chikungunya Vaccine, Receives FDA Approval!

    WHO-Emergency-Meeting-Scheduled-Amidst-Gaza-and-West-Bank-Health-Crisis-thehealthcaredaily

    WHO Emergency Meeting Scheduled Amidst Gaza and West Bank Health Crisis

    Controversy-Surrounds-NMC's-Logo-Featuring-Hindu-Deity-thehealthcaredaily

    Controversy Surrounds NMC’s Logo Featuring Hindu Deity

    Bollywood-Star-Ranveer-Singh-Bold-Step-Into-Sexual-Health-Advocacy-thehealthcaredaily

    Bollywood Star Ranveer Singh’s Bold Step Into Sexual Health Advocacy

    Said-Pneumonia-Outbreak-in-China-Prompts-Concerns-Among-Indian-States-thehealthcaredaily

    Said Pneumonia Outbreak in China Prompts Concerns in Indian States

    World-AIDS-Day-2023-Communities-Commended-for-Pioneering-Efforts-in-HIV-Response-thehealthcaredaily

    World AIDS Day 2023: Communities Commended for Pioneering Efforts in HIV Response

    Health-Community-Raises-Urgent-Climate-Change-and-Health-Concerns-Ahead-of-COP28-thehealthcaredaily

    Health Community Raises Urgent Climate Change and Health Concerns Ahead of COP28

    Indian-Health-Ministry-Urge- Vigilance-as-Respiratory-Illness-Clusters-Emerge-thehealthcaredaily

    Indian Health Ministry Urges Vigilance as Respiratory Illness Clusters Emerge in China

    Health-Crisis-in-Gaza-Continue-sWHO's-High-Risk-Evacuation-Mission-thehealthcaredaily

    Health Crisis in Gaza Continues, WHO’s High-Risk Evacuation Mission

  • Insights
    • All
    • Analysis
    • Interview
    • Opinion
    • Reports
    Gynecomastia

    Gynecomastia: Balancing Act – Dangers, Benefits, and Decision-Making

    Inspiring Journeys to Health and Wellness

    Medical Tourism Success Stories: Inspiring Journeys to Health and Wellness

    Wellness Tourism: Understanding Its Mind-Boggling Significance in Your Life

    World-AIDS-Day-2023-Communities-Commended-for-Pioneering-Efforts-in-HIV-Response-thehealthcaredaily

    World AIDS Day 2023: Communities Commended for Pioneering Efforts in HIV Response

    Understanding-Allergies-Identifying-Triggers-and-Seeking-Effective-Treatments-thehealthcaredaily

    Allergies Insight: Identifying Triggers and Pursuing Effective Remedial Measures

    Exploring-Women's-Reproductive-Right-A-Fundamental-Introduction-thehealthcaredaily

    Exploring Women’s Reproductive Rights: A Fundamental Introduction

    Managing Autoimmune Disorders: Lifestyle and Diet Strategies

    Understanding Celiac Disease: Symptoms, Causes, and Diagnosis

    Understanding-Multiple-Sclerosis-Symptoms-Causes,-and-Treatments-thehealthcaredaily

    Understanding Multiple Sclerosis: Symptoms, Causes, and Treatments

  • HealthTech
    • All
    • Hardware
    • Innovation
    • Software
    Augmenting Humanity

    Navigating the Ethical Frontiers of Technological Enhancement – Augmenting Humanity

    Leading Healthcare Cybersecurity Firms: The Best 5

    AI-Powered Diagnostics: Revolutionizing Healthcare with Speed and Precision

    Aidoc Secures $30 Million Funding to Revolutionize AI Imaging

    Telemedicine-in-Healthcare-2023-An-Evaluation-of-Its-Advantages-and-Disadvantages-thehealthcaredaily

    Telemedicine in Healthcare: An Evaluation of Its Advantages and Disadvantages

    A Journey into the Brain: Exploring the Wonders of Deep Brain Stimulation

    Everything-about-Personalized-Medicine-in-2023-Healthcare-Daily

    The Promise of Personalized Medicine: Unlocking a Better Future of Medicine

    10-Most-Promising-Breakthroughs-in-Medical-Research-Thehealthcaredaily

    10 Most Promising Breakthroughs in Medical Research

    Overview-of-healthcare-hackathons-and-competitions-focused-on-healthcare-innovation-thehealthcaredaily

    Overview of healthcare hackathons and competitions focused on healthcare innovation

  • Pharma
  • Events
  • NewsMakers
  • World
  • Home
  • News
    • All
    • Biotech
    • By Speciality
    • Generic Drugs
    • Insurance
    • Investment
    • Medical Tourism
    • Pharma
    Ixchiq-the-Chikungunya-Vaccine-Receives-FDA-Approval-thehealthcaredaily

    Ixchiq, the Chikungunya Vaccine, Receives FDA Approval!

    WHO-Emergency-Meeting-Scheduled-Amidst-Gaza-and-West-Bank-Health-Crisis-thehealthcaredaily

    WHO Emergency Meeting Scheduled Amidst Gaza and West Bank Health Crisis

    Controversy-Surrounds-NMC's-Logo-Featuring-Hindu-Deity-thehealthcaredaily

    Controversy Surrounds NMC’s Logo Featuring Hindu Deity

    Bollywood-Star-Ranveer-Singh-Bold-Step-Into-Sexual-Health-Advocacy-thehealthcaredaily

    Bollywood Star Ranveer Singh’s Bold Step Into Sexual Health Advocacy

    Said-Pneumonia-Outbreak-in-China-Prompts-Concerns-Among-Indian-States-thehealthcaredaily

    Said Pneumonia Outbreak in China Prompts Concerns in Indian States

    World-AIDS-Day-2023-Communities-Commended-for-Pioneering-Efforts-in-HIV-Response-thehealthcaredaily

    World AIDS Day 2023: Communities Commended for Pioneering Efforts in HIV Response

    Health-Community-Raises-Urgent-Climate-Change-and-Health-Concerns-Ahead-of-COP28-thehealthcaredaily

    Health Community Raises Urgent Climate Change and Health Concerns Ahead of COP28

    Indian-Health-Ministry-Urge- Vigilance-as-Respiratory-Illness-Clusters-Emerge-thehealthcaredaily

    Indian Health Ministry Urges Vigilance as Respiratory Illness Clusters Emerge in China

    Health-Crisis-in-Gaza-Continue-sWHO's-High-Risk-Evacuation-Mission-thehealthcaredaily

    Health Crisis in Gaza Continues, WHO’s High-Risk Evacuation Mission

  • Insights
    • All
    • Analysis
    • Interview
    • Opinion
    • Reports
    Gynecomastia

    Gynecomastia: Balancing Act – Dangers, Benefits, and Decision-Making

    Inspiring Journeys to Health and Wellness

    Medical Tourism Success Stories: Inspiring Journeys to Health and Wellness

    Wellness Tourism: Understanding Its Mind-Boggling Significance in Your Life

    World-AIDS-Day-2023-Communities-Commended-for-Pioneering-Efforts-in-HIV-Response-thehealthcaredaily

    World AIDS Day 2023: Communities Commended for Pioneering Efforts in HIV Response

    Understanding-Allergies-Identifying-Triggers-and-Seeking-Effective-Treatments-thehealthcaredaily

    Allergies Insight: Identifying Triggers and Pursuing Effective Remedial Measures

    Exploring-Women's-Reproductive-Right-A-Fundamental-Introduction-thehealthcaredaily

    Exploring Women’s Reproductive Rights: A Fundamental Introduction

    Managing Autoimmune Disorders: Lifestyle and Diet Strategies

    Understanding Celiac Disease: Symptoms, Causes, and Diagnosis

    Understanding-Multiple-Sclerosis-Symptoms-Causes,-and-Treatments-thehealthcaredaily

    Understanding Multiple Sclerosis: Symptoms, Causes, and Treatments

  • HealthTech
    • All
    • Hardware
    • Innovation
    • Software
    Augmenting Humanity

    Navigating the Ethical Frontiers of Technological Enhancement – Augmenting Humanity

    Leading Healthcare Cybersecurity Firms: The Best 5

    AI-Powered Diagnostics: Revolutionizing Healthcare with Speed and Precision

    Aidoc Secures $30 Million Funding to Revolutionize AI Imaging

    Telemedicine-in-Healthcare-2023-An-Evaluation-of-Its-Advantages-and-Disadvantages-thehealthcaredaily

    Telemedicine in Healthcare: An Evaluation of Its Advantages and Disadvantages

    A Journey into the Brain: Exploring the Wonders of Deep Brain Stimulation

    Everything-about-Personalized-Medicine-in-2023-Healthcare-Daily

    The Promise of Personalized Medicine: Unlocking a Better Future of Medicine

    10-Most-Promising-Breakthroughs-in-Medical-Research-Thehealthcaredaily

    10 Most Promising Breakthroughs in Medical Research

    Overview-of-healthcare-hackathons-and-competitions-focused-on-healthcare-innovation-thehealthcaredaily

    Overview of healthcare hackathons and competitions focused on healthcare innovation

  • Pharma
  • Events
  • NewsMakers
  • World
No Result
View All Result
The Healthcare Daily
No Result
View All Result
Home Featured

Auvelity: Auvelity a medication for major depressive disorders

Auvelity, a recently approved medication for major depressive disorder, will have difficulties with payer pricing and reimbursement.

by Admin
October 6, 2022
in Featured, Health, News
Reading Time: 3 mins read
0
Auvelity for major depressive disorder might face pricing and reimbursement issues

Source: Google Images

0
SHARES
Share on FacebookShare on Twitter

Table of Contents

Toggle
  • Main highlights 
  • The pricing and reimbursement issues for Auvelity’s 

Main highlights: 

  • FDA authorized ‘Auvelity’ for major depressive disorder
  • The pricing and reimbursement issues for Auvelity

The FDA authorized Auvelity (dextromethorphan/bupropion) extended-release tablets from Axsome Therapeutics in August for the treatment of major depressive disorder (MDD) in adults. Dextromethorphan, a cough suppressant, and bupropion, an antidepressant, are the two active chemicals of Auvelity, which have both been around for more than two decades. Nevertheless, Auvelity represents the market entry of oral medication with a unique mechanism of action for MDD in more than 60 years.

A breakthrough in the MDD market, where there is an unmet need for medications that can exhibit quick antidepressant benefits, can be shown in Auvelity’s quick beginning of the action. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors are currently the standards of therapy (SNRIs). After several weeks of treatment, these drugs start to have an antidepressant effect.

The fact that consuming Auvelity was not linked to weight gain in a Phase 3 study supports the drug’s rapid and (probably) long-lasting antidepressant benefits. There are many anti-depressants on the market now that can cause weight gain.

The GEMINI placebo-controlled study and the ASCEND research contrasting Auvelity and bupropion sustained-release tablets provided crucial evidence for the approval of Auvelity. Notably, the ASCEND research, a comparison trial, revealed that Auvelity outperformed bupropion on the key outcome metric by a statistically significant margin.

An oral antidepressant that requires a prescription is called Auvelity. Major depressive disorder (depression) in adults is a condition that is FDA-approved to treat. Dextromethorphan and bupropion are both present in it as an extended-release (ER) tablet.

The FDA’s priority list seemed to have this drug combination at the top of the list. Auvelity was designated a breakthrough therapy by the FDA before approval. Additionally, they performed a priority review evaluation of the drug.

The manufacturer of Auvelity is the American pharmaceutical business Axsome Therapeutics.

Auvelity designed for MDD might face pricing and reimbursement issues
Source: Google Images

The pricing and reimbursement issues for Auvelity’s 

Despite Auvelity’s advantages that have been shown in clinical trials, pricing and reimbursement issues will arise for this new pharmaceutical, as they do for the majority of newly licensed medications in classes where there are several (less expensive) therapy options. Axsome hasn’t yet disclosed its cost, but it is believed that it will be more expensive than generic SSRIs and SNRIs, which are already well-known on the MDD market. Due to its anticipated high cost, payers may limit the use of Auvelity to second and subsequent lines of therapy.

Not that Auvelity won’t be covered—far from it. If Axsome Therapeutics participates in the Medicaid Drug Rebate Program, it will likely be added to formularies by many commercial insurers as well as by all Medicaid plans. Additionally, because it is an antidepressant, it qualifies as a protected medication class and should be covered by all Medicare Part D plans.

Coverage, though, is a complicated affair. Being included in the formulary or being omitted is not the only option for coverage. Most recently approved medications eventually land on the formulary. But what really matters is where they stand on the formulary.

The terms of reimbursement that payers impose, such as patient cost-sharing, prior authorization, step edits, quantity caps, and indication restrictions, influence access in this case. These reimbursement requirements also depend on a variety of elements, including the cost per unit, rebates, the therapeutic interchangeability of the product with other ones, clinical and financial effectiveness, and fiscal implications.

The sponsor of Auvelity, Axsome Therapeutics, will face difficulties in overcoming barriers to market access. But a strong efficacy and safety profile will probably make it easier for patients to get access.

Admin

Admin

Next Post
How sex can affect your fertility

Fertility: How sex can affect your fertility?

Recommended

Asia-Pacific-Health-Ministers-Strive-to-Attain-Universal-Health-Coverage-WHO

Asia-Pacific Health Ministers Strive to Attain Universal Health Coverage

5 years ago

New study in Cancer; indication of response to immunotherapy

5 years ago

About Us

A daily dose of news, views, opinions, and actionable information from the global healthcare industry. Our newsletter is available for a limited audience. If you are interested to write or contribute to this portal then please get in touch.

Important Links

  • Home
  • World
  • Business
  • Health

Recent News

Gynecomastia: Balancing Act – Dangers, Benefits, and Decision-Making

Medical Tourism Success Stories: Inspiring Journeys to Health and Wellness

  • About
  • Submit Article/PR
  • Contact

© 2025 - The Healthcare Daily

No Result
View All Result
  • Home
  • World
  • Business
  • Health

© 2025 - The Healthcare Daily

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In